Literature DB >> 25224917

Neuropsychiatric symptoms in dementia-a role for neuroinflammation?

Simon Holmgren1, Erik Hjorth2, Marianne Schultzberg2, Marie Lärksäter3, Dan Frenkel4, Ann Christine Tysen-Bäckström3, Dag Aarsland5, Yvonne Freund-Levi6.   

Abstract

Dementia is characterized by a progressive cognitive decline and neuropsychiatric symptoms (NPSD) such as agitation, apathy and sleeping problems. There is some evidence of activation of inflammatory pathways in the brain in dementia, but little research has been performed regarding the role of neuroinflammation in NPSD, which might represent a potential novel target for treatment. The aim of this study was to examine the possible association between NPSD and cerebrospinal fluid (CSF) levels of the cytokines IL-6, TNF-α and IL-10, and the cytokine receptor sIL-1RII, in patients with dementia and NPSD. Ninety-four patients (mean age 79±8; 67% female) with a score on the neuropsychiatric inventory (NPI) ≥10 points, were included. Clinical assessment included administration of NPI, the mini-mental state examination (MMSE) and the Cohen-Mansfield agitation inventory (CMAI). The cytokine levels in CSF samples were analysed by enzyme-linked immunosorbent assay. Correlations were statistically examined using Spearman's rank correlation coefficient (r), and simple- and multiple-linear regression. The anti-inflammatory cytokine IL-10 showed reverse correlations with total NPI score (NPI-total=-0.001, t(90)= 8.50, p=0.004) and NPI sub-items agitation (agitation=-0.007, t(90)=7.02, p=0.009) and night-time behaviour (night time behaviour=-0.006, t(90)=6.34, p=0.01). There was a trend towards reverse correlation between IL-10 and depression (depression=-0.004, t(90)=2.96, p=0.09). Also, the soluble cytokine receptor sIL-1RII showed a trend towards correlation with apathy (apathy=0.82, t(82)=3.62, p=0.06). The levels of IL-6 showed no significant correlations with NPSD. Levels of TNF-α were non-detectable. In Alzheimer's disease (AD) subjects (n=33), IL-6 showed reverse correlation with anxiety (r=-0.35, p=0.049). In mixed AD subjects (n=26), IL-10 showed reverse correlations with the total NPI score (r=-0.46, p=0.02) and depression (r=-0.45, p=0.02). The findings indicate a relationship between neuroinflammation and neuropsychiatric symptoms in AD in which anti-inflammatory signalling by IL-10 is beneficial from a mental health perspective.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; BPSD; Behavioural symptoms; Cerebrospinal fluid; Cytokines; NPSD

Mesh:

Substances:

Year:  2014        PMID: 25224917     DOI: 10.1016/j.brainresbull.2014.09.003

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  12 in total

1.  Age-related hearing loss and dementia: a 10-year national population-based study.

Authors:  Peijen Su; Chih-Chao Hsu; Hung-Ching Lin; Wei-Shin Huang; Tsung-Lin Yang; Wei-Ting Hsu; Cheng-Li Lin; Chung-Yi Hsu; Kuang-Hsi Chang; Yi-Chao Hsu
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-02-22       Impact factor: 2.503

2.  Neuropsychiatric Symptoms in Dementia: Considering a Clinical Role for Electroencephalography.

Authors:  Simon Holmgren; Thomas Andersson; Anders Berglund; Dag Aarsland; Jeffrey Cummings; Yvonne Freund-Levi
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2022-03-21       Impact factor: 2.891

3.  Blood DNA Methylation Levels in the WNT5A Gene Promoter Region: A Potential Biomarker for Agitation in Subjects with Dementia.

Authors:  Nobuyuki Kobayashi; Shunichiro Shinagawa; Tomoyuki Nagata; Kenji Tagai; Kazuya Shimada; Azusa Ishii; Naomi Oka; Masahiro Shigeta; Kazuhiro Kondo
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

4.  Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysis.

Authors:  Glen P Martin; Kathryn R McDonald; David Allsop; Peter J Diggle; Iracema Leroi
Journal:  J Neurol       Date:  2019-10-15       Impact factor: 4.849

Review 5.  The Role of Heart Rate Variability in the Future of Remote Digital Biomarkers.

Authors:  Andrew P Owens
Journal:  Front Neurosci       Date:  2020-11-13       Impact factor: 4.677

Review 6.  Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets.

Authors:  Silvia Pasquini; Chiara Contri; Stefania Merighi; Stefania Gessi; Pier Andrea Borea; Katia Varani; Fabrizio Vincenzi
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

Review 7.  Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and -specific lesion patterns.

Authors:  Yaojing Chen; Mingxi Dang; Zhanjun Zhang
Journal:  Mol Neurodegener       Date:  2021-06-07       Impact factor: 14.195

Review 8.  Promising Intervention Approaches to Potentially Resolve Neuroinflammation And Steroid Hormones Alterations in Alzheimer's Disease and Its Neuropsychiatric Symptoms.

Authors:  Catia Scassellati; Antonio Carlo Galoforo; Ciro Esposito; Miriam Ciani; Giovanni Ricevuti; Cristian Bonvicini
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

9.  Alterations of the Neuroinflammatory Markers IL-6 and TRAIL in Alzheimer's Disease.

Authors:  Ya-Ying Wu; Jung-Lung Hsu; Han-Cheng Wang; Shyh-Jong Wu; Chen-Jee Hong; Irene Han-Juo Cheng
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-11-24

10.  Protective Effects of Quercetin on Anxiety-Like Symptoms and Neuroinflammation Induced by Lipopolysaccharide in Rats.

Authors:  Bombi Lee; Mijung Yeom; Insop Shim; Hyejung Lee; Dae-Hyun Hahm
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.